Campbell & CO Investment Adviser LLC

Position in VTRS — Viatris Inc

CIK 1353570 BALTIMORE, MD

Back to VTRS Full portfolio

Position in VTRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,443,303

+$2,873,433 QoQ

Shares Held

328,890

+160.8% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $18,794,275 across 13 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (23.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc This page	328,890	$4,443,303
2	UTHR	UNITED THERAPEUTICS Corp	6,434	$3,815,233
3	INDV	Indivior Pharmaceuticals, Inc.	96,079	$2,928,487
4	COLL	Collegium Pharmaceutical, Inc	73,233	$2,421,815
5	PAHC	Phibro Animal Health Corp	27,606	$1,526,887
6	AMLX	Amylyx Pharmaceuticals, Inc.	54,422	$756,465
7	AMRX	Amneal Pharmaceuticals, Inc.	60,620	$753,506
8	HLN	Haleon plc	64,274	$643,382

All Filings in VTRS

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,443,303	328,890	+160.8%	Shares	Sole	2026-05-15
2025-12-31	$1,569,870	126,094	+35.2%	Shares	Sole	2026-02-12
2025-09-30	$923,155	93,248	+15.5%	Shares	Sole	2025-10-28
2025-06-30	$720,793	80,716	+7.1%	Shares	Sole	2025-08-07
2025-03-31	$656,281	75,348	+295.9%	Shares	Sole	2025-05-14
2024-12-31	$236,935	19,031	-10.1%	Shares	Sole	2025-02-10
2024-09-30	$245,783	21,170	-57.8%	Shares	Sole	2024-11-12
2024-06-30	$533,455	50,184	+65.3%	Shares	Sole	2024-08-13
2024-03-31	$362,558	30,365	-47.8%	Shares	Sole	2024-05-10
2023-12-31	$629,656	58,140	+10.3%	Shares	Sole	2024-02-13
2023-09-30	$519,779	52,716	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.